Clinical trial
Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study
NCT02025205 · Pulmonx International Sàrl, Industry · Completed
Key facts
| NCT number | NCT02025205 |
|---|---|
| Title | Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study |
| Official title | A Multicentre, Prospective, Randomized, Controlled, One-way Crossover Investigation of Endobronchial Valve (EBV) Therapy vs. Standard of Care (SoC) in Homogeneous Emphysema |
| Acronym | IMPACT |
| Lead sponsor | Pulmonx International Sàrl, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | COPD Patients With Homogeneous Emphysema, Endoscopic Lung Volume Reduction With Endobronchial Valve |
| Intervention type | Device |
| Interventions | Endobronchial Valve |
| Enrollment | 93 |
| Start date | Aug 1, 2014 |
| Primary completion | Apr 1, 2016 |
| Completion | Mar 15, 2017 |
| First posted | Dec 31, 2013 |
| Last update posted | Aug 16, 2019 |
| Countries | Austria, Germany, Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: